Institut Pasteur Korea to screen Pfizer compound library

Published: 2009-12-09 06:58:00

Updated: 2009-12-09 06:58:00

Institut Pasteur Korea said on December 7 that it has entered into a Collaborative Agreement with the Drugs for Neglected Diseases Initiative (DNDi), centered on the use of Pfizer’s compound library, for the identification and development of safe, effective and affordable new treatments for patie...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK